Ciprofol is one of 197 small molecule programs targeting Sedation. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
261 competitors in Liver Cancer
Nexavar
Opdivo
Eloxatin
Adriamycin
Platinol
Imjudo
Gemzar
Adriamycin
Bayer Aspirin
Megace
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details